Partner Lynda Zadra-Symes quoted in, “US Perspectives: Must All Foreigners Online Comply with US Copyright Law?,” an article posted in Intellectual Property Watch. Excerpt: US copyright law is supposed to apply…
Partner Eli A. Loots, Ph.D. quoted in, “How Comprehensive Do IPR Decisions Have To Be?” an article posted in Pink Sheet. Excerpt: Supreme Court to consider whether Patent Trial and Appeal Board must…
Partner Eli A. Loots, Ph.D. quoted in, “Will Inter Partes Review Go Away? Supreme Court Weighs Fate,” an article posted in Pink Sheet. Excerpt: Biopharma and generic industries stand on opposing sides in…
Partner Jonathan Bachand and Associate Ashley Morales co-authored, “Hatch-Waxman And Copying: An Exception To The Exception?” which was published in Law360. Excerpt: Over a year ago, in a Law360 Expert Analysis article, we set…
The OptiScanner® 5000 is an automated, bedside glucose monitoring system that provides physicians with information on plasma glucose levels in the SICU. Through automated monitoring of a patient’s glucose values,…
Partner Jon Gurka quoted in, “Micron Ruling May Spark New Wave Of Venue Fights,” an article posted in Law360. Excerpt: The Federal Circuit’s decision Wednesday that TC Heartland was a change…
Knobbe Martens has been consistently recognized by U.S. News & World Report and Best Lawyers, as a “Best Law Firm” for its patent law and litigation practices. This year, the…
Partner Douglas Muehlhauser quoted in, “Giant Slayers: Douglas Muehlhauser, Knobbe Martens” an article posted in The Recorder. Excerpt: Douglas Muehlhauser of Knobbe Martens scored a comeback win at the U.S. Court of…
Partners Agnes Juang, Ph.D., and Daniel A. Kamkar co-authored, “The Complex Litigation Surrounding Remicade And Its Biosimilar Challengers” which was published in Biosimilar Development. Excerpt: Janssen Biotech Inc. and Celltrion Healthcare are engaged…
Federal Circuit Denies En Banc Rehearing in Mentor Graphics v. EVE-USA In Mentor Graphics Corp. v. Eve-USA, Inc., Appeal Nos. 2015-1470, 2015-1554, 2015-1556, the Federal Circuit denied Synopsys’ and EVE’s…
